Increasing evidence advocates the prognostic role of RDW in various tumours. We analysed 591 patients to assess whether RDW is a prognostic factor for overall (oS) and cancer-related survival (cRS) for patients with colorectal cancer (cRc). the data were retrieved from a retrospective database. the optimal cutoff value for RDW was set at 14.1%; accordingly, two groups were considered: those with a value equal or lower than 14.1% (L-RDW), and those with a value higher than 14.1% (H-RDW). The mean value of RDW rose from pT1 to pT4 tumours. H-RDW correlated with age above the mean, colonic location of the lesion, pT and TNM stage. Finally, H-RDW was significantly associated with the intent of surgery: almost 50% of patients who underwent a non-curative resection presented H-RDW, compared to 19.3% in R0 resections. OS was significantly lower in patients with H-RDW. CRS was similar in the two groups. Stratifying patients according to TNM stage worse OS was associated with H-RDW only in early stages, whereas there was no difference for stages II-IV. Multivariate analysis confirmed that H-RDW was not an independent prognostic factor. Although H-RDW correlated with some negative clinicalpathological factors, it did not seem to independently influence OS and CRS. Colorectal cancer (CRC) is the third most common cancer worldwide, with more than 1 million new cases and 600.000 deaths per year 1. Several biochemical markers related to the inflammatory processes that accompanies this malignancy have recently surged as diagnostic and prognostic tools 2-4. Beside classical 'inflammatory related' markers such as acute phase proteins (CRP and globulins), also parameters that reflect changes in certain bone marrow lineages such as PLR and NLR have been described 2,5. Amongst these, red blood cell distribution width (RDW) is a parameter that reflects the size heterogeneity of red blood cells and is normally used to differentiate various types of anemia 6. More recently, RDW has surged as a biochemical marker in several chronic inflammatory and cardiovascular disease 7-9. Recent reports have shown how it can be used as a prognostic marker in various cancer such as, lung, liver, esophago-gastric and breast 10-15. RDW has been studied as a potential prognostic marker also in CRC. In the context of this malignancy, however, its role remains unclear, as reports so far published have shown inconsistent results. The aim of this retrospective study was to evaluate the prognostic value of red blood cell distribution width in a large cohort of patients undergoing surgery for colorectal cancer.